Mukka Proteins' GST Litigation Concluded, Nil Demand Order Received
Mukka Proteins Limited received a final order on 18th December 2025 concluding GST litigation for FY 2021-22. Initially proposed ₹141.06 crore demand was reduced to ₹27.16 lakh, and the final order resulted in a nil demand for tax, interest, penalty, or late fee. The litigation is now fully resolved.
The resolution of a substantial tax dispute, even with an initial proposed demand, removes a significant overhang and potential financial risk for the company.
The company received a final order with a nil demand, resolving a significant tax litigation matter without any financial liability.
Mukka Proteins Limited has received a final Order under Section 73 of the CGST/GGST Act, 2017, along with Form GST DRC -07 dated 18th December 2025, passed by the State Tax Officer, Porbandar (Gujarat). This order concludes the proceedings initiated by a previous Show Cause Notice.
Initially, the company had received a GST demand proposal of approximately ₹141.06 crore for FY 2021–22 due to alleged discrepancies in GST returns. Following the company's reply, the proposed demand was reduced to ₹27.16 lakh via a Show Cause Notice. However, the final order issued on 18th December 2025 reflects a nil demand for tax, interest, penalty, or late fee.
Consequently, the litigation stands fully resolved with no financial liability subsisting against Mukka Proteins Limited concerning this matter.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.